Home Xushui Interconnect Secures Tens of Millions in Pre-A Funding Led by Yuanyi Capital to Advance AIoT Solutions for Smart Hospital Management

Xushui Interconnect Secures Tens of Millions in Pre-A Funding Led by Yuanyi Capital to Advance AIoT Solutions for Smart Hospital Management

Sep 13, 2021 08:00 CST Updated 08:00

VCBeat has learned that,Aquiferre (hereinafter referred to as "Aquiferre") has recently completed a financing round worth tens of millions of yuanPre-Series A financing, led by Yuanyi Capital, with follow-on investment from Wu Anhua, co-founder of ThunderSoft.Previously, Aquiferre had receivedKaisixuandaandHongtai Medical GroupStrategic investment of tens of millions of yuan.

 

This round of financing will be primarily used forDrive the company’s R&D in AIoT-enabled medical devices and digital applications, accelerate the commercial deployment of related outcomes among hospital clients, and explore and promote relevant industry standards and specifications.

 

Aquiferre, founded in 2016, is a deep-tech company specializing in AIoT applications for medical devices. Leveraging its independently developed digital twin technology, the company drives intelligent management transformation of medical equipment and establishes a standardized platform for digital achievement conversion at Grade IIIA hospitals, utilizing real-world data to advance smart hospital management upgrades.

 

High-Quality Digital Transformation Poised for Takeoff


Driven by the new healthcare reforms, public hospitals have gradually shifted from relying on revenue generated from pharmaceuticals, consumables, medical devices, and diagnostic tests to prioritizing high-quality returns through healthcare services, with quality and efficiency serving as the key engines for enhancing performance. Amidst the new wave of promoting high-quality development in public hospitals, leveraging digital transformation to improve service quality and management standards has become an imperative necessity.

 

According to statistical data compiled from the National Health Commission,As of 2019, the total asset value of medical equipment in China reached RMB 1.5 trillion, with 200,000 units valued at over RMB 1 million and 7 million units valued at over RMB 10,000, growing at a rapid annual rate of 13%.

 

Meanwhile, due to the uneven distribution of medical resources, there is significant imbalance in both the quality and efficiency of their utilization. Under the new health insurance payment system and the new hospital performance evaluation framework, how medical equipment—as a critical production resource second only to physicians—can maximize its support for high-quality hospital development has become a pressing issue for all hospital administrators.

 

From this demand perspective, Aquiferre has provided hospitals with a systematic solution that has already been commercially implemented in multiple leading hospitals.

 

Specifically, Aquiferre leverages data mining, data analytics, and data heterogeneity to provide an integrated platform solution for remote monitoring and early warning of medical devices, standardized quality control and performance management, configuration optimization and procurement decision-making, as well as big data analysis and translational research. This empowers real-world data to drive efficiency and support the advancement of smart hospitals.

 

图片1.png

Aquiferre’s Products Have Been Successfully Deployed at Multiple Hospital Clients

 

As of now, Aquiferre has entered into cooperation agreements with renowned domestic hospital clients, including Peking Union Medical College Hospital and West China Hospital of Sichuan University, regarding the smart IoT application platform for medical equipment.

 

Amid the deepening reforms in DRG-based payment, performance appraisal of tertiary public hospitals, and compensation systems for public hospitals, the conversion of leading hospitals into paying customers not only demonstrates the competitiveness and unique application value of Aquiferre’s products, but also lays a solid foundation for the company’s rapid market expansion in the next phase.

 

Five Years of Dedication, Initial Success


Aquiferre has been in operation for five years since its establishment.

 

Over the past five years, Aquiferre has systematically completed foundational architecture research for nearly 100 categories of large and medium-sized medical devices. By leveraging its independently developed AIoT smart hardware to bridge the “last mile” of device data interoperability, the company has achieved comprehensive sensing of medical equipment data along with automated cleaning and extraction of unstructured data. This has enabled the creation of a full-stack solution based on digitalized equipment management, tailored for hospital administrators at all levels.

 

However, Aquiferre is not content to rest on its laurels. Building on this foundation, Aquiferre has leveraged the technological combination of “Trusted Cloud + Edge Computing” to jointly create a network architecture that meets the information security requirements of hospitals, balancing application scalability with the security of in-hospital data.

 

Currently, Aquiferre’s independently developed smart IoT application platform for medical equipment has connected thousands of large-scale medical devices across more than 1,000 hospitals. The system’s compatibility and stability have been thoroughly validated through years of practical application.Filed over 40 patents in related technical fields.

 

Delivering such a satisfactory result in a short period of time would not have been possible without Aquiferre’s solid background and long-term investment in research and development. It is reported that,80% of Aquiferre’s team members come from the R&D and sales departments of large medical device manufacturers., leveraging its accumulated expertise in the physical principles, application scenarios, and business models of medical devices, it has gained deep insights into the significant supply-demand imbalances and efficiency losses that still persist within the industry.

 

Hospital-Centric, Hard Tech as the Main Thread


The inherent nature of the healthcare industry dictates that hospitals remain the core of the healthcare system’s operation.

 

Aquiferre recognized this from the outset, and has therefore remained committed to a hospital-centric approach in product development, building digital infrastructure to support the full lifecycle management of medical equipment.

 

Aquiferre’s independently developed AIoT digital twin technology helps hospitals build a medical device data middle platform with consistent standards across device categories, brands, information systems, and geographic locations, as well as a digital application transformation platform based on multi-dimensional data fusion.

 

This smart IoT system digitizes regulatory evaluation, quality control, usage standards, management decision-making, and data protection related to medical equipment in Grade A tertiary hospitals, enabling efficient commercialization of outcomes through the company’s nationwide AIoT application platform.

 

Looking ahead, Aquiferre plans toIntegrating digital twin technology with high-quality medical resources to accelerate the replication and decentralization of these resources, thereby enhancing the quality of care and management capabilities across the entire healthcare industry.Meanwhile, Yuanyi’s investment will accelerate the development and launch of Aquiferre’s new application products and significantly advance its commercialization efforts.

 

As an investor in this round,Tang Yinan, Investment Director at Yuanyi CapitalFrom the perspective of industry demand, she stated, “In the new environment of high-quality development in public hospitals, hospital administrators generally lack effective tools for refined management, with significant pain points that urgently require innovative technologies to bring about change. As an early-stage investor, Yuanyi Capital is firmly optimistic about the vast market potential in the digital application of medical devices.”

 

Regarding Aquiferre itself, Tang Yinan recognizes the company’s substantial growth potential for the future. She stated, “Aquiferre has entered a critical, high-barrier infrastructure segment within the digital transformation of hospital management—the Intelligent Medical Equipment Management Platform—providing hospital administrators with powerful digital management tools that effectively enhance equipment operational efficiency. The Aquiferre team boasts strong industry expertise, learning agility, and execution capabilities. Over the past five years since its founding, the company has remained focused on deepening its specialization, adhering to a customer-centric approach, and leading industry development. As a pioneer in applying industrial internet technologies to the healthcare sector, Aquiferre provides essential infrastructure for hospital digitalization and has earned high recognition from top-tier hospitals. Yuanyi Capital is optimistic about the company’s continued innovation in technology and business models, which will drive deeper integration of IT and OT, continuously launch new products and applications, and help customers improve capabilities and efficiency across equipment, operations, and collaboration dimensions, thereby delivering sustained value to the industry.”

 

>>>>

About Yuanyi Capital


Yuan Yi Capital, established in 2016, is an early-stage venture capital fund focused on the digital health technology sector. It targets early-stage companies in medical devices and equipment with core technologies and innovative business models, precision diagnostics, mobile healthcare and services, and health insurance technology firms. Its recent investments include MedShine Health (commercial health insurance technology), Shukun Technology (AI-based medical imaging), Realshining Technology (digital dental solutions), Mingyi Zhonghe (primary care-focused healthcare), Beideng Medical (a B2B trading platform for medical devices), and Jizhun Medical (early cancer screening based on gene sequencing).